Results posted on the Bombay Stock Exchange (BSE) shows that Aurobindo Pharma's total income from operations rose to Rs.2,175.93 crore from Rs.2,007.70 crore.
Embattled Drugmaker Valeant Pharmaceuticals Cuts Ties to Philidor RX
Valeant has lost confidence in Philidor's ability to continue to operate in a manner that is acceptable to Valeant and the patients and doctors we serve.
Valeant has lost confidence in Philidor's ability to continue to operate in a manner that is acceptable to Valeant and the patients and doctors we serve.
‘Pharmaceutical manufacturer Aurobindo Pharma posted a net profit of Rs.451.76 crore in Q2 against Rs.372.18 crore, while total income from operations rose to Rs.3,333.43 crore from Rs.2,881.22 crore.’
On consolidated basis, Aurobindo Pharma posted a net profit of Rs.451.76 crore in Q2 against Rs.372.18 crore in the last quarter, while total income from operations rose to Rs.3,333.43 crore from Rs.2,881.22 crore. Aurobindo Pharma incurred a total expenditure of Rs.2,650.65 crore in the reviewed quarter on a consolidated basis against Rs.2,333.86 crore in the previous quarter.
Source-IANS
Sun Pharmaceuticals Recalls 10 Lakh Boxes Of Anti-Allergy Drug From US Market
The anti-allergic drug, Loratadine is an antihistamine used to treat the symptoms of allergies, such as sneezing, watery eyes, and runny nose.
The anti-allergic drug, Loratadine is an antihistamine used to treat the symptoms of allergies, such as sneezing, watery eyes, and runny nose.
Mumbai-Based Elder Pharmaceuticals To Clear All Dues By Selling Assets
Elder Pharmaceuticals is a major player in the anti-infectives, multi- vitamins, cardiology and skincare segments apart from the OTC space.
Elder Pharmaceuticals is a major player in the anti-infectives, multi- vitamins, cardiology and skincare segments apart from the OTC space.
Glenmark Pharmaceuticals Inks Pact With Poland Based Celon for Generic Seretide Accuhaler
As per the terms of the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries.
As per the terms of the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries.
